Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
13 MG melatonin----[1] 13 💬
25 MG melatonin----[1] 13 💬
3Diazepam, melatonin[1] Diazepam[1] Diazepam 💬 [16] GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRB,
GABRB,
GABRB,
GABRD,
GABRE,
GABRG,
GABRG,
GABRG,
GABRP,
GABRQ 💬
[8] GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬[1] 46 💬
4Extended release melatonin----[1] 6 💬
5Hourly dosing OF THE nychtemeral secretion OF melatonin----[1] 202 💬
6Immediate release melatonin----[1] 6 💬
7Melatonin[1] Melatonin (Melatonin)[1] Melatonin (Melatonin, Melatonina) 💬 [2] MTNR1A,
MTNR1B 💬
[2] Circadian entrainment, Neuroactive ligand-receptor interaction 💬[16] 2, 6, 8, 13, 37, 46, 49, 72, 78, 86, 90, 96, 97, 145, 149, 202 💬
8Melatonin CR[1] Melatonin (Melatonin)[1] Melatonin (Melatonin, Melatonina) 💬 [2] MTNR1A,
MTNR1B 💬
[2] Circadian entrainment, Neuroactive ligand-receptor interaction 💬[1] 202 💬
9Melatonin PR[1] Melatonin (Melatonin)[1] Melatonin (Melatonin, Melatonina) 💬 [2] MTNR1A,
MTNR1B 💬
[2] Circadian entrainment, Neuroactive ligand-receptor interaction 💬[1] 6 💬
10Melatonin supplementation[1] Melatonin (Melatonin)[1] Melatonin (Melatonin, Melatonina) 💬 [2] MTNR1A,
MTNR1B 💬
[2] Circadian entrainment, Neuroactive ligand-receptor interaction 💬[1] 265 💬